CN Stock MarketDetailed Quotes

Tibet Duo Rui Pharmaceutical (301075)

Watchlist
  • 94.31
  • +3.79+4.19%
Market Closed Mar 10 15:00 CST
7.54BMarket Cap-94.59P/E (TTM)

Tibet Duo Rui Pharmaceutical (301075) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Total special adjustments59.01M55.37%
艾博韦泰22.95M21.53%
醋酸钠林格注射液11.12M10.43%
注射用阿莫西林钠克拉维酸钾11.06M10.38%
Other business2.44M2.29%

By Industry

Currency:CNY
2025/H1
Stock NameRevenueRatio
Preparation40.07M37.60%
Intermediate38.13M35.78%
Raw material medicine23.06M21.64%
Other5.31M4.98%

By Country/Region

Currency:CNY
2024/FY
Stock NameRevenueRatio
Domestic240.63M100.00%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
View More
Nancy Pelosi Portfolio
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the ongoing conflict between the US and Iran has continued to unsettle the stock market. However, the latest reports suggest that Show More